The biggest blockade in cancer care isnt a lack of science #shorts
In this YouTube short, speaker Dino Prato, NMD, argues that the primary obstacle to advancing cancer treatment is not a lack of scientific knowledge but the regulatory and systemic framework that enforces a one‑size‑fits‑all model. He emphasizes that cancer is a highly individual disease and that precision oncology—driven by detailed biomarker testing and personalized treatment plans—should replace generic standard‑of‑care protocols. Prato highlights the opportunity to combine the best of conventional medicine, integrative therapies, and immunotherapy when precise molecular data are available. He calls for the FDA to recognize and support biomarker‑guided, custom‑built treatment regimens, asserting that such regulatory flexibility would accelerate the delivery of life‑extending, personalized cancer care.
